Irinotecan + Temozolomide for sarcoma, ewing

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jul 2022: Trial registered, NCT05440786
  2. 20 Sep 2022: Trial started, NCT05440786

The trials

NCT05440786: CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

State
Under way
Phase
Phase 2
People
46 taking part
Started
20 Sep 2022
Primary completion
15 Jan 2025
Arms
Irinotecan +Temozolomide
Results
Posted on the registry
  1. 1 Jul 2022: Trial registered
  2. 20 Sep 2022: Trial started
  3. 12 Mar 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.